Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

PJ Online | News: Start steroids early in meningitis

Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7225 p732
23 November 2002

This article

News summary

Related websites
New England Journal of Medicine: abstract (more)

Start steroids early in meningitis

Early treatment with dexamethasone improves outcome in patients with acute bacterial meningitis, a new study shows.

Researchers randomly assigned adult patients with acute bacterial meningitis to receive either dexamethasone 10mg (n=157) or placebo (n=144), taken 15 to 20 minutes before or with the first dose of antibiotic and then every six hours for four days.

Adjuvant treatment with dexamethasone reduced the risk of an unfavourable outcome (death, a vegetative state or moderate or severe disability) by 10 per cent (absolute risk reduction) compared with placebo (15 per cent versus 25 per cent). The proportion of patients who died was 7 per cent in the dexamethasone group and 15 per cent in the placebo group. Although dexamethasone was found to be of benefit in those with pneumococcal meningitis it did not provide a significant benefit in those with meningitis due to Neisseria meningitidis. Of the 108 patients with pneumococcal meningitis, 26 per cent in the dexamethasone group had an unfavourable outcome compared with 52 per cent in the placebo group. However, the researchers recommend that a four-day regimen of dexamethasone 10mg given every six hours, starting before or with the first dose of antibiotics, should be given to all patients with acute bacterial meningitis.

The study is published in The New England Journal of Medicine (2002;347:1549).

Back to Top

Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal

Citation: The Pharmaceutical Journal URI: 20008233

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.